BCLI News Alert Brainstorm Cell Ther (BCLI) 5.00 01/06/2015

New Post Public Reply Private Reply Replies (0) Message Board

Jan 6, 2015 at 6:24 PM

Brainstorm Cell Ther (BCLI) 5.00 $BCLI

Brainstorm Takes Major Leap Forward In Battle Vs. ALS
Jason Napodano, CFA - Seeking Alpha - Tue Jan 06, 9:51AM CST
By Jason Napodano On Monday, January 5, 2015 Brainstorm Cell Therapeutics (NASDAQ: BCLI ) announced final results from the Phase 2a clinical trial of NurOwn as a treatment for patients suffering from amyotrophic lateral sclerosis (ALS). Below we...
BCLI: 5.00 (-0.75)

BrainStorm CEO to Present at Two Upcoming Investor Conferences
PR Newswire - Tue Jan 06, 6:05AM CST
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that Tony Fiorino, MD, PhD, Chief Executive Officer, will be presenting at two upcoming investor conferences.
BCLI: 5.00 (-0.75)

A Look At BrainStorm Cell Therapeutics' ALS Phase IIa Results
Wall Street Titan - at Seeking Alpha - Mon Jan 05, 2:48PM CST

ATHX: 2.00 (+0.18), BCLI: 5.00 (-0.75)

15 Biotech Names For 2015
Jason Napodano, CFA - at Seeking Alpha - Mon Jan 05, 1:37PM CST

NBIX: 20.53 (-0.87), LPCN: 5.07 (-0.19), EPRS: 5.96 (+0.11), DEPO: 15.80 (-0.23), ASPX: 50.78 (-2.21), BCLI: 5.00 (-0.75), CUR: 3.35 (+0.37)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 11:48AM CST

SD: 1.41 (-0.12), XENT: 20.23 (-0.50), WLL: 29.40 (-0.34), BTE: 14.21 (-0.50), BOTA: 2.65 (-0.20), CNAT: 10.63 (+0.57), WG: 5.40 (+0.01), SN: 8.39 (+0.05), LPI: 8.42 (-0.95), EROC: 2.16 (-0.04), BCLI: 5.00 (-0.75), NDRM: 15.45 (+1.80), SMLR: 2.69 (+0.34), QURE: 17.23 (+0.07), SFY: 3.23 (+0.07), ANTH: 2.20 (-0.07), PLX: 2.02 (-0.15), APRI: 1.31 (-0.03), STXS: 1.70 (-0.18), GST: 2.14 (-0.14)

Investors bag some profits on Brainstorm
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 10:56AM CST

BCLI: 5.00 (-0.75)

Brainstorm Stem-Cell Therapy Continues to Show Treatment Effect in ALS Patients
at The Street - Mon Jan 05, 9:52AM CST
Final results from a mid-stage study of Brainstorm's NurOwn therapy show a slowing of disease progression in some ALS patients.
BCLI: 5.00 (-0.75)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 8:10AM CST

CERS: 5.78 (-0.79), E: 32.08 (+0.12), SSL: 34.64 (-0.36), CNAT: 10.63 (+0.57), SDRL: 10.48 (-0.33), NBG: 1.58 (-0.08), BCLI: 5.00 (-0.75), URZ: 1.20 (+0.02), PBR: 6.02 (-0.05), ISIS: 65.44 (-2.73), KITE: 71.45 (+1.70), PLX: 2.02 (-0.15), CEMP: 23.15 (-1.40), STXS: 1.70 (-0.18)

BrainStorm Announces Final Analysis of Phase 2a ALS Study Showing Nearly All Subjects Experienced Clinical Benefit from NurOwn(TM)
PR Newswire - Mon Jan 05, 7:20AM CST
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced positive final results from its phase 2a clinical trial of NurOwn(TM) in amyotrophic lateral sclerosis (ALS) patients, which enrolled 14 subjects at Hadassah Medical Center in Jerusalem.
BCLI: 5.00 (-0.75)

Stocks in Whipsaw to Start 2015 as Weak Manufacturing Blunts Optimism
at The Street - Fri Jan 02, 3:20PM CST
Wall Street will likely excuse the bumpy start to the year as traders focus on a busy week ahead.
MU: 32.87 (-0.91), PSMT: 89.85 (+0.15), MON: 116.25 (-1.06), SYNA: 60.43 (-3.29), GBX: 49.31 (-2.76), WYNN: 141.31 (-3.08), LVS: 53.36 (-1.40), FDO: 78.67 (+0.01), HNR: 0.90 (-0.07), MGM: 19.66 (-0.78), BCLI: 5.00 (-0.75), RAD: 7.71 (+0.19), BLDP: 1.74 (-0.04), AYI: 134.81 (-1.71), AA: 15.07 (+0.11), BBBY: 75.42 (-0.43), SONC: 27.09 (+0.05)

Rite Aid and Petrobras are big market movers
AP - Fri Jan 02, 3:11PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
BLDP: 1.74 (-0.04), BLD.TO: 2.04 (-0.06), GNTX: 17.16 (-0.35), HNR: 0.90 (-0.07), BCLI: 5.00 (-0.75), RAD: 7.71 (+0.19)

Stocks Yo-Yo as U.S. Manufacturing Activity Hits Six-Month Low
at The Street - Fri Jan 02, 1:39PM CST
Indications of weakness in manufacturing serve to reverse the S&P 500 which had jumped at the open.
BLDP: 1.74 (-0.04), SYNA: 60.43 (-3.29), WYNN: 141.31 (-3.08), LVS: 53.36 (-1.40), MGM: 19.66 (-0.78), HNR: 0.90 (-0.07), BCLI: 5.00 (-0.75), RAD: 7.71 (+0.19)

Stocks Turn Negative as U.S. Manufacturing Slides to Six-Month Low
at The Street - Fri Jan 02, 9:49AM CST
The stock market rallied in the first trading day of the year as positive sentiment carried over into 2015.
BLDP: 1.74 (-0.04), BBBY: 75.42 (-0.43), BCLI: 5.00 (-0.75), RAD: 7.71 (+0.19)

Brainstorm Cell Therapeutics (BCLI) Stock Hits One-Year High Today
at The Street - Fri Jan 02, 8:53AM CST
Shares of Brainstorm Cell Therapeutics (BCLI) soared more than 75% to a 52-week high of $8.47 on Friday ahead of the biotech company's data release on Monday.
BCLI: 5.00 (-0.75)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 8:14AM CST

KOOL: 1.00 (-0.02), BLDP: 1.74 (-0.04), PBR: 6.02 (-0.05), LNCO: 11.31 (+0.09), KITE: 71.45 (+1.70), NRX: 9.28 (-0.87), LINE: 11.22 (+0.07), PWRD: 19.10 (+0.11), BCLI: 5.00 (-0.75), CUR: 3.35 (+0.37)

Brainstorm up big premarket on NurOwn results in ALS
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 7:27AM CST

BCLI: 5.00 (-0.75)

Stock Futures Point to Positive Open in First Session of 2015
at The Street - Fri Jan 02, 7:12AM CST
Stock futures look to kick off 2015 with gusto on the first trading day of the year.
BBBY: 75.42 (-0.43), LINE: 11.22 (+0.07), BCLI: 5.00 (-0.75)

Happy New 'Investing' Year: Complementary Reports on Daily Journal, Trina Solar, Cytokinetics, BrainStorm, and Resolute
PR Newswire - Fri Jan 02, 7:10AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Daily Journal (NASDAQ: DJCO), Trina Solar (NYSE: TSL), Cytokinetics (NASDAQ: CYTK), BrainStorm (NASDAQ: BCLI), and Resolute (NYSE: REN). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
CYTK: 7.22 (-0.45), REN: 1.03 (-0.06), TSL: 8.79 (-0.30), DJCO: 229.98 (-0.20), BCLI: 5.00 (-0.75)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zions Bank Spurs Idaho's Small Biz Boom in 2026

Riding the Small Business Tsunami in Idaho You don't hear it every day, but Idaho's small business scene is hotter than a frypan—a nod to the entrepreneurial fire blazing in the state, and Zions Bank is holding the torch. In 2026, despite dealing with the uphill battles of inflation, tariffs, and labor scarcity, those entrepreneurs still managed to carve out a spot at...

Global Vineyards List: New Entrants & Rankings Unveiled

Vineyards' Global Ranking Unveiled Wine enthusiasts and globetrotters have something to toast about this November. The 50 Best Vineyards just expanded its ranking to reveal the vineyards sitting in spots 51 through 100 for 2026. This list, spotlighting some of the globe's finest wine destinations, precedes the main awards ceremony set for November 18 in Santiago, Chile....

Understanding Hired & Non-Owned Auto Insurance Basics

The Overlooked Gap in Auto Coverage Bet you didn't see this one coming: businesses often overestimate their auto insurance coverage, assuming their commercial policies cover all the bases. When employees drive personal vehicles for work purposes or when businesses borrow rides temporarily, these assumptions leave a gaping hole bigger than a sinkhole in a Florida street....

ABYSS Revolutionizes Infrastructure Management with New Tech

Pioneering Transformation in Infrastructure Management Ever felt like infrastructure management's been stuck in the stone age? Well, Houston's own ABYSS just kicked that notion to the curb. Formerly Abyss Solutions, they're relaunching themselves with a new mission that might just set the industry on fire. They're calling it the Asset Operating Environment, and trust me,...

PNU and Cellenkos Team Up for Biotech Advancements

Paving New Paths in Biotech Collaboration When a university and a biotech company shake hands to bolster their capabilities in the ever-evolving field of clinical trials and cell and gene therapies, investors and industry buffs alike should perk up. The College of Medicine at Princess Nourah bint Abdulrahman University (PNU) has just inked a Memorandum of Understanding...

ALIF Holding Secures First Federal Contract: A Milestone

ALIF Holding's Landmark Contract Snagging a federal contract right off the bat is like hitting a home run your first time at bat. ALIF Holding has landed its inaugural agreement with a federal government-owned giant, securing four key sites up in the Northern Emirates. That's no small feat, folks, especially for a company still making its name in Abu Dhabi's crowded tech...

VILVA's Global Reach: Power Testing's Next Phase

A Power Play on Global Markets Taking a page from its relentless pursuit of quality and innovation, VILVA Electronics is bolstering its foothold on the international stage. Based in Shenzhen, this savvy player is reaching out for strategic partners like fishing for that perfect bite, hoping to reel in catches that understand the nitty-gritty of the local ponds—their...

Gildan Faces Class Action Over Alleged Market Missteps

Legal Storm Brews Over Gildan's Securities Conduct Listen, investors are no strangers to turbulence. But when a company's integrity takes a nosedive, that's when things get precarious fast. Gildan Activewear Inc. (NYSE: GIL) finds itself neck-deep in legal trouble, thanks to alleged securities law violations. On November 9, 2026, DJS Law Group got the ball rolling on a...

Paratus Energy Lands Petrobras Tender, Ties Finalizing

Seagems Joint Venture Snags Petrobras Contract Let’s dive headfirst into this business update, because this one's got teeth, folks. Petrobras, the big dog in Brazil’s oil arena, has given the green light to Seagems’ bid, a joint venture half-owned by Paratus Energy Services Ltd. The target? A hefty pipe-laying support vessel (PLSV) contract starting in 2028. But...

Tom Hanks' New Campaign Boosts Veterans' Morale

Coffee and Kindness: Tom Hanks' Salute to Veterans Alright, let's dive right into the steaming pot that is Tom Hanks' latest venture, shall we? The man who’s charmed us on screen is stirring up another kind of magic off it. Hanks For Our Troops, his coffee company, is launching a campaign aptly named "(T)HANKS"—a nationwide blitz to honor and empower our veterans this...